First Patient Dosed in ProstACT Program for Prostate Cancer Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. CHWY
4. NAVN
5. USO
6. SPCX
7. HUMA
8. CME
9. cASY
10. TSLA

Go back to First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.44 --0 (-0%)
Previous Close $9.44    52 Week High $2.18 
Open $9.44    52 Week Low $0.30 
Day High $9.44    P/E N/A 
Day Low $9.44    EPS $-3.32 
Volume 11